1-20 of 41
apolipoproteins b
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

408-P: Associations between Apolipoprotein B (apoB): Apolipoprotein A1 (apoA1) Ratio and Metabolic and Kidney Disease in Youth with Type 1 Diabetes

LAURYN REMMERS, CARISSA BIRZNIEKS, DIEGO CARRASCO, SUSAN GROSS, JANET K. SNELL-BERGEON, LUCY A. HALL, KRISTEN J. NADEAU, PETTER BJORNSTAD, KALIE L. TOMMERDAHL
Journal: Diabetes
Diabetes 2023;72(Supplement_1):408-P
https://doi.org/10.2337/db23-408-P
Published: 20 June 2023
View article titled, 408-P: Associations between Apolipoprotein B (apoB): Apolipoprotein A1 (apoA1) Ratio and Metabolic and Kidney Disease in Youth with Type 1 Diabetes
Meeting Abstracts

260-OR: The ApoB/LDL-C Ratio Predicts Major Cardiovascular Events in Cardiovascular Disease Patients Independent of Type 2 Diabetes Status

BARBARA LARCHER, MAXIMILIAN MAECHLER, LUKAS SPRENGER, ARTHUR MADER, ALEXANDER VONBANK, THOMAS PLATTNER, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Journal: Diabetes
Diabetes 2023;72(Supplement_1):260-OR
https://doi.org/10.2337/db23-260-OR
Published: 20 June 2023
View article titled, 260-OR: The ApoB/LDL-C Ratio Predicts Major Cardiovascular Events in Cardiovascular Disease Patients Independent of Type 2 Diabetes Status
Meeting Abstracts

1096-P: The LDL-C/apoB Ratio Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with Nonalcoholic Fatty Liver Disease as Well as in Those without Nonalcoholic Fatty Liver Disease

MAXIMILIAN MAECHLER, LUKAS SPRENGER, ARTHUR MADER, BARBARA LARCHER, ALEXANDER VONBANK, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1096-P
https://doi.org/10.2337/db22-1096-P
Published: 01 June 2022
View article titled, 1096-P: The LDL-C/apoB Ratio Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with Nonalcoholic Fatty Liver Disease as Well as in Those without Nonalcoholic Fatty Liver Disease
Meeting Abstracts

Effects of a High-Carb vs. High-Fat Meal on Glycemia, Insulin, Interleukin-6, TNF-Alpha, and Apo-B

HELMUT O. STEINBERG, FRANKIE B. STENTZ, NANDITA K. SHANKAR
Journal: Diabetes
Diabetes 2018;67(Supplement_1):265-LB
https://doi.org/10.2337/db18-265-LB
Published: 01 July 2018
View article titled, Effects of a High-Carb vs. High-Fat Meal on Glycemia, Insulin, Interleukin-6, TNF-Alpha, and Apo-B
Journal Articles

Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish

Huichun Xu, Kathleen A. Ryan, Thomas J. Jaworek, Lorraine Southam, Jeffrey G. Reid, John D. Overton, Aris Baras, Marja K. Puurunen, Eleftheria Zeggini, Simeon I. Taylor, Alan R. Shuldiner, Braxton D. Mitchell
Journal: Diabetes
Diabetes 2017;66(7):2054–2058
https://doi.org/10.2337/db17-0173
Published: 20 April 2017
View article titled, Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish
Open the PDF for Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish in another window
Journal Articles

Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol

Changting Xiao, Satya Dash, Cecilia Morgantini, Robert A. Hegele, Gary F. Lewis
Journal: Diabetes
Diabetes 2016;65(7):1767–1778
https://doi.org/10.2337/db16-0046
Published: 13 June 2016
View article titled, Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol
Open the PDF for Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol in another window
Journal Articles

Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism

Changting Xiao, Satya Dash, Cecilia Morgantini, Khosrow Adeli, Gary F. Lewis
Journal: Diabetes
Diabetes 2015;64(7):2310–2318
https://doi.org/10.2337/db14-1706
Published: 17 June 2015
View article titled, Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism
Open the PDF for Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism in another window
Journal Articles

Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans

Changting Xiao, Satya Dash, Cecilia Morgantini, Bruce W. Patterson, Gary F. Lewis
Journal: Diabetes
Diabetes 2014;63(7):2394–2401
https://doi.org/10.2337/db13-1654
Published: 14 June 2014
View article titled, Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans
Open the PDF for Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans in another window
Includes: Supplementary data
Journal Articles

Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes

Muhammad Bayu Sasongko, Tien Y. Wong, Thanh T. Nguyen, Ryo Kawasaki, Alicia J. Jenkins, Jonathan Shaw, Carol Robinson, Jie Jin Wang
Journal: Diabetes
Diabetes 2012;61(7):1785–1792
https://doi.org/10.2337/db11-1272
Published: 15 June 2012
View article titled, Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes
Open the PDF for Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes in another window
Includes: Supplementary data
Journal Articles

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Anne Hiukka, Marcus Ståhlman, Camilla Pettersson, Malin Levin, Martin Adiels, Susanne Teneberg, Eeva S. Leinonen, Lillemor Mattsson Hultén, Olov Wiklund, Matej Orešič, Sven-Olof Olofsson, Marja-Riitta Taskinen, Kim Ekroos, Jan Borén
Journal: Diabetes
Diabetes 2009;58(9):2018–2026
https://doi.org/10.2337/db09-0206
Published: 05 June 2009
View article titled, ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
Open the PDF for ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan in another window
Includes: Supplementary data
Journal Articles

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites

Seth S. Martin, Atif N. Qasim, Nehal N. Mehta, Megan Wolfe, Karen Terembula, Stanley Schwartz, Nayyar Iqbal, Mark Schutta, Roshanak Bagheri, Muredach P. Reilly
Journal: Diabetes
Diabetes 2009;58(8):1887–1892
https://doi.org/10.2337/db08-1794
Published: 02 June 2009
View article titled, Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
Open the PDF for Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites in another window
Includes: Supplementary data
Journal Articles

Diabetes, Abdominal Adiposity, and Atherogenic Dyslipoproteinemia in Women Compared With Men

Ken Williams, Andre Tchernof, Kelly J. Hunt, Lynne E. Wagenknecht, Steven M. Haffner, Allan D. Sniderman
Journal: Diabetes
Diabetes 2008;57(12):3289–3296
https://doi.org/10.2337/db08-0787
Published: 01 December 2008
View article titled, Diabetes, Abdominal Adiposity, and Atherogenic Dyslipoproteinemia in Women Compared With Men
Open the PDF for Diabetes, Abdominal Adiposity, and Atherogenic Dyslipoproteinemia in Women Compared With Men in another window
Journal Articles

Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism

Liping Qiao, Chenhui Zou, Deneys R. van der Westhuyzen, Jianhua Shao
Journal: Diabetes
Diabetes 2008;57(7):1824–1833
https://doi.org/10.2337/db07-0435
Published: 01 July 2008
View article titled, Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
Open the PDF for Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism in another window
Includes: Supplementary data
Journal Articles

Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes

Ira J. Goldberg, Yunying Hu, Hye-Lim Noh, Justin Wei, Lesley Ann Huggins, Marnie G. Rackmill, Hiroko Hamai, Brendan N. Reid, William S. Blaner, Li-Shin Huang
Journal: Diabetes
Diabetes 2008;57(6):1674–1682
https://doi.org/10.2337/db08-0083
Published: 01 June 2008
View article titled, Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes
Open the PDF for Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes in another window
Journal Articles

Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men

Ulf Risérus, Dennis Sprecher, Tony Johnson, Eric Olson, Sandra Hirschberg, Aixue Liu, Zeke Fang, Priti Hegde, Duncan Richards, Leli Sarov-Blat, Jay C. Strum, Samar Basu, Jane Cheeseman, Barbara A. Fielding, Sandy M. Humphreys, Theodore Danoff, Niall R. Moore, Peter Murgatroyd, Stephen O'Rahilly, Pauline Sutton, Tim Willson, David Hassall, Keith N. Frayn, Fredrik Karpe
Journal: Diabetes
Diabetes 2008;57(2):332–339
https://doi.org/10.2337/db07-1318
Published: 01 February 2008
View article titled, Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men
Open the PDF for Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men in another window
Includes: Supplementary data
Journal Articles

Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes

Theodore Mazzone, Peter M. Meyer, George T. Kondos, Michael H. Davidson, Steven B. Feinstein, Ralph B. D’Agostino, Sr., Alfonso Perez, Steven M. Haffner
Journal: Diabetes
Diabetes 2007;56(3):849–855
https://doi.org/10.2337/db06-0935
Published: 01 March 2007
View article titled, Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes
Open the PDF for Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes in another window
Journal Articles

Common Polymorphisms in the Promoter of the Visfatin Gene (PBEF1) Influence Plasma Insulin Levels in a French-Canadian Population

Swneke D. Bailey, J C. Loredo-Osti, Pierre Lepage, Janet Faith, Joelle Fontaine, Katia M. Desbiens, Thomas J. Hudson, Claude Bouchard, Daniel Gaudet, Louis Pérusse, Marie-Claude Vohl, James C. Engert
Journal: Diabetes
Diabetes 2006;55(10):2896–2902
https://doi.org/10.2337/db06-0189
Published: 01 October 2006
View article titled, Common Polymorphisms in the Promoter of the Visfatin Gene (<em>PBEF1</em>) Influence Plasma Insulin Levels in a French-Canadian Population
Open the PDF for Common Polymorphisms in the Promoter of the Visfatin Gene (<em>PBEF1</em>) Influence Plasma Insulin Levels in a French-Canadian Population in another window
Includes: Supplementary data
Journal Articles

Adipocytokines and VLDL Metabolism: Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics?

Theodore W.K. Ng, Gerald F. Watts, Maryam S. Farvid, Dick C. Chan, P. Hugh R. Barrett
Journal: Diabetes
Diabetes 2005;54(3):795–802
https://doi.org/10.2337/diabetes.54.3.795
Published: 01 March 2005
View article titled, Adipocytokines and VLDL Metabolism: <subtitle>Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics?</subtitle>
Open the PDF for Adipocytokines and VLDL Metabolism: <subtitle>Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics?</subtitle> in another window
Journal Articles

Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women

Marie-Ève Piché, S. John Weisnagel, Louise Corneau, André Nadeau, Jean Bergeron, Simone Lemieux
Journal: Diabetes
Diabetes 2005;54(3):770–777
https://doi.org/10.2337/diabetes.54.3.770
Published: 01 March 2005
View article titled, Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women
Open the PDF for Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women in another window
Journal Articles

Hepatic PTP-1B Expression Regulates the Assembly and Secretion of Apolipoprotein B–Containing Lipoproteins: Evidence From Protein Tyrosine Phosphatase-1B Overexpression, Knockout, and RNAi Studies

Wei Qiu, Rita Kohen Avramoglu, Nadia Dubé, Taryne M. Chong, Mark Naples, Crystal Au, Konstantinos G. Sidiropoulos, Gary F. Lewis, Jeffrey S. Cohn, Michel L. Tremblay, Khosrow Adeli
Journal: Diabetes
Diabetes 2004;53(12):3057–3066
https://doi.org/10.2337/diabetes.53.12.3057
Published: 01 December 2004
View article titled, Hepatic <em>PTP-1B</em> Expression Regulates the Assembly and Secretion of Apolipoprotein <em>B</em>–Containing Lipoproteins: <subtitle>Evidence From Protein Tyrosine Phosphatase-1<em>B</em> Overexpression, Knockout, and <em>RNAi</em> Studies</subtitle>
Open the PDF for Hepatic <em>PTP-1B</em> Expression Regulates the Assembly and Secretion of Apolipoprotein <em>B</em>–Containing Lipoproteins: <subtitle>Evidence From Protein Tyrosine Phosphatase-1<em>B</em> Overexpression, Knockout, and <em>RNAi</em> Studies</subtitle> in another window